| 000 | 01273 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511175530.0 | ||
| 264 | 0 | _c19930604 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a1046-7890 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArnold, L E | |
| 245 | 0 | 0 |
_aQuantifying the value of human life for cost accounting of safeguards: clarifying formulas applied to the clozapine controversy. _h[electronic resource] |
| 260 |
_bThe Journal of clinical ethics _c1992 |
||
| 300 |
_a103-8; discussion 108-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aEconomics, Medical |
| 650 | 0 | 4 | _aEthics |
| 650 | 0 | 4 | _aFederal Government |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aManagement Information Systems |
| 650 | 0 | 4 | _aPersons with Psychiatric Disorders |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPublic Policy |
| 650 | 0 | 4 | _aResource Allocation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSocial Justice |
| 650 | 0 | 4 | _aTherapeutic Human Experimentation |
| 650 | 0 | 4 | _aValue of Life |
| 773 | 0 |
_tThe Journal of clinical ethics _gvol. 3 _gno. 2 _gp. 103-8; discussion 108-13 |
|
| 999 |
_c1308360 _d1308360 |
||